Related Experiment Video
Updated: Apr 21, 2026

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
Genetic evaluation for TOR1-A (DYT1) in Brazilian patients with dystonia
Carlos Henrique F Camargo1, Sarah Teixeira Camargos2, Salmo Raskin3
1Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brazil.
Unlabelled:
Several genes have been mapped in families or in sporadic cases of dystonia. TOR1-A (DYT1) gene was linked to isolated dystonia.
Objective:
To associate clinical information of patients with dystonia with the TOR1-A gene mutations.
Method:
Eighty-eight patients with dystonia in cervical area (focal, segmental, multifocal and generalized) were recruited at Movement Disorders Clinic of Hospital de Clínicas of the Federal University of Paraná between June of 2008 and June of 2009. They were submitted to the clinical evaluation. DNA was extract from blood and submitted at analysis to TOR1-A mutations by PCR according standard protocols.
Results:
Two patients had c.907GAGdel mutation on TOR1-A gene. These patients, with familial history of dystonia, started his symptoms by legs and had secondary generalization.
Conclusion:
We can suggest that analysis for TOR1-A mutations should be performed only in patients with early onset, generalized and familial dystonia.
Related Concept Videos
Incomplete Dominance
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Alterations in Muscle Tone ll

